John P. Fruehauf

Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.

Eugene Mechetner, Ainura Kyshtoobayeva, Svetlana Zonis et al. · PubMed · 1998 · 291 citations

Medicine, Oncology, Pharmacology +13

BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma

Kevin B. Kim, Jeffrey A. Sosman, John P. Fruehauf et al. · Journal of Clinical Oncology · 2011 · 196 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors

Brian I. Rini, Joan H. Schiller, John P. Fruehauf et al. · Clinical Cancer Research · 2011 · 179 citations · Full text

Medicine, Oncology, Pharmacology +15

Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer

Min‐Ying Su, Yun‐Chung Cheung, John P. Fruehauf et al. · Journal of Magnetic Resonance Imaging · 2003 · 153 citations

Medicine, Oncology, Radiology +17

Prediction of Drug Response in Breast Cancer Using Integrative Experimental/Computational Modeling

Hermann B. Frieboes, Mary E. Edgerton, John P. Fruehauf et al. · Cancer Research · 2009 · 145 citations · Full text

Medicine, Cancer Biology, Oncology +17